Do COVID-19 RNA-based vaccines put at risk of immune-mediated diseases? In reply to “potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases”
Rossella Talotta
Topics & Concepts
Coronavirus disease 2019 (COVID-19)Immune systemVirologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakAntigenCross-reactivityImmunologyBiologyMedicineCross reactionsDiseaseInfectious disease (medical specialty)OutbreakPathologySARS-CoV-2 and COVID-19 ResearchImmunotherapy and Immune ResponsesAnimal Virus Infections Studies